, /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2026 earnings which ended on June 30, 2026, on Tuesday, August 4, 2026, after the market closes.
The Company will host a conference call and live webcast to discuss its financial results the following day, Wednesday, August 5, 2026, at 8:30 a.m. Eastern Time. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events. A replay will be available beginning at 8:30 a.m. ET on August 6, 2026.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.
, /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the completion of the previously disclosed sale of its B Medical Systems business to Thelema S.à r.l.
The transaction was originally announced on December 29, 2025 and closed on July 1, 2026 following the satisfaction of all closing conditions. Under the terms of the agreement, Azenta sold B Medical Systems for a fixed purchase price of $63 million in cash, of which $35 million was funded through a short-term secured vendor loan from an Azenta subsidiary to Thelema. Additional details regarding the transaction are available in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission.
"The completion of this transaction advances our strategy to simplify and focus the portfolio on our core life sciences businesses," said John Marotta, President and Chief Executive Officer of Azenta. "With enhanced financial flexibility and a continued focus on our core growth platforms, we are well positioned to drive sustainable growth and long-term value for our shareholders."
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling life science organizations around the world to bring impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.
This press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding the expected benefits of the completed transaction, the Company's future strategic priorities and capital allocation plans, and the anticipated repayment or refinancing of the vendor loan described above. These forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements, including: Thelema's ability to complete its third-party financing to repay the vendor loan at or prior to maturity; the risk of a default by Thelema under the vendor loan; the Company's ability to realize the expected benefits of the transaction and to execute on its strategic priorities and capital allocation plans; and the other factors described in the Company's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. Any forward-looking statement in this press release speaks only as of the date on which it is made, and, except as required by applicable law, the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether because of new information, future developments or otherwise.
NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ:AZTA) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
[LEARN MORE ABOUT THE INVESTIGATION]
What Happened?
On May 5, 2026, Azenta reported its second quarter fiscal 2026 financial results and updated its full-year outlook. Among other things, the Company disclosed that its second quarter results “fell short” of expectations, reflecting “both execution gaps and a more cautious demand environment.” Azenta further disclosed that results were impacted by “costs related to Automated Stores rework” and that the Company recorded a $149 million non-cash goodwill impairment charge during the quarter. In addition, Azenta reduced its fiscal 2026 outlook, stating that organic revenue was now expected to range from down approximately 2% to up 1%, compared to prior guidance of 3% to 5% growth. The Company also reduced its adjusted EBITDA margin outlook and announced that it was extending the timeline for its long-range plan targets from 2028 to 2029. On this news, the price of Azenta shares declined by $6.23 per share, or approximately 25%, from $24.61 per share on May 5, 2026 to close at $18.38 on May 6, 2026.
What Should I Do?
At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.
If you purchased or otherwise acquired Azenta securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at [email protected], or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.
[LEARN MORE ABOUT SECURITES CLASS ACTIONS]
Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Azenta and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On May 5, 2026, Azenta reported its second quarter fiscal 2026 financial results and updated its full-year outlook. Among other items, the Company disclosed that its second quarter results “fell short” of expectations, reflecting “both execution gaps and a more cautious demand environment.” Azenta further disclosed that results were impacted by “costs related to Automated Stores rework” and that the Company recorded a $149 million non-cash goodwill impairment charge during the quarter. In addition, Azenta reduced its fiscal 2026 outlook, stating that organic revenue was now expected to range from down approximately 2% to up 1%, compared to prior guidance of 3% to 5% growth. The Company also reduced its adjusted EBITDA margin outlook and announced that it was extending the timeline for its long-range plan targets from 2028 to 2029.
On this news, Azenta’s stock price fell $6.23 per share, or 25.31%, to close at $18.38 per share on May 6, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Azenta (AZTA) To Contact Him Directly To Discuss Their Options
If you purchased or acquired stock in Azenta and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.
Click here to participate in the action.
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) --
What’s Happening:
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ:AZTA) on behalf of Azenta stockholders. Our investigation concerns whether Azenta has violated the federal securities laws and/or engaged in other unlawful business practices. Investigation Details:
On May 5, 2026, Azenta announced its financial results for the second quarter of fiscal 2026 and revised its full-year guidance. Among other disclosures, the Company stated that its second quarter performance “fell short” of expectations, citing “both execution gaps and a more cautious demand environment.” Azenta also disclosed that the quarter’s results were affected by “costs related to Automated Stores rework” and that it had recorded a $149 million non-cash goodwill impairment charge during the quarter. Additionally, the Company lowered its fiscal 2026 outlook, stating that it now expected organic revenue to range from a decline of approximately 2% to growth of 1%, compared to its previous guidance of 3% to 5% growth. Azenta further reduced its adjusted EBITDA margin outlook and announced that it was extending the timeline for achieving its long-range plan targets from 2028 to 2029. Following this news, Azenta’s share price fell by $6.23 per share, or approximately 25%, declining from $24.61 per share on May 5, 2026 to close at $18.38 per share on May 6, 2026. Next Steps:
If you purchased or otherwise acquired Azenta shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities,
derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn.
Azenta, Inc. reported Q2 FY 2026 results that included a $160.8 million net loss and a $149 million goodwill impairment -- erasing prior guidance and shareholder value.
, /PRNewswire/ -- Shareholders who held Azenta, Inc. (NASDAQ: AZTA) stock lost significant value when the Company disclosed Q2 FY 2026 results on May 5, 2026, revealing a $160.8 million net loss driven by a $149 million goodwill impairment charge. The Company simultaneously cut its full-year FY 2026 revenue and margin guidance -- guidance it had reaffirmed just three months earlier. Those who purchased AZTA shares and suffered a loss are encouraged to submit their information to Levi & Korsinsky . You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.
On February 4, 2026, CEO John Marotta told investors Azenta was "entering the year well positioned for continued success" and reaffirmed FY 2026 guidance of 3%-5% organic revenue growth with approximately 300 basis points of adjusted EBITDA margin expansion. On May 5, 2026, the Company reported Q2 FY 2026 results that included a $149 million goodwill impairment charge in its Multiomics segment. The resulting net loss of $160.8 million stood in stark contrast to the growth trajectory management had presented ninety days prior.
Alongside the impairment, Azenta reduced its full-year FY 2026 guidance -- trimming the revenue growth and margin expansion targets it had publicly reaffirmed in February. The gap between the Company's stated outlook and its reported results is now the subject of an investigation into potential securities law violations.
Shareholders who lost money on their AZTA investment may click here to discuss their legal rights with Levi & Korsinsky . You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.
ABOUT THE FIRM -- For over two decades, Levi & Korsinsky has represented shareholders in securities investigations and recoveries. Ranked in ISS Top 50 for seven consecutive years.
Frequently Asked Questions About the AZTA Investigation
Q: How much did AZTA stock drop? A: Azenta shares declined sharply after the Company disclosed a $149 million goodwill impairment and a $160.8 million net loss in its Q2 FY 2026 results on May 5, 2026. The Company also cut its previously reaffirmed FY 2026 guidance. Investors who purchased shares at higher prices may be eligible to participate in the investigation.
Q: Who is conducting the AZTA investigation? A: Levi & Korsinsky, LLP is investigating potential securities law violations on behalf of investors who purchased AZTA securities and suffered financial losses. The firm is nationally recognized, ranked in the ISS Top 50 for seven consecutive years, and has recovered hundreds of millions of dollars for aggrieved investors.
Q: Who is eligible to participate in the AZTA investigation? A: Investors who purchased AZTA stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.
Q: What do AZTA investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500. No immediate action is required to remain eligible to participate in the investigation.
Q: What if I already sold my AZTA shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought AZTA and sold at a loss may still participate in the investigation.
Q: What does it cost me to participate? A: Nothing. Securities investigations and any resulting actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.
Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions. The overwhelming majority of affected investors never appear in court.
Azenta, Inc. reaffirmed 3%-5% organic revenue growth and 300 basis points of margin expansion in February 2026 -- then disclosed a $149 million goodwill impairment and slashed guidance three months later May 21, 2026 09:00 ET | Source: Levi & Korsinsky, LLP
NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- Investors in Azenta, Inc. (NASDAQ: AZTA) suffered significant losses after the Company disclosed a $149 million goodwill impairment in its Q2 FY 2026 results on May 5, 2026, alongside a $160.8 million net loss and a substantial reduction in its full-year outlook. Shareholders who lost money on their Azenta investment are encouraged to submit their information to Levi & Korsinsky. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.
During the Q1 2026 earnings call on February 4, 2026, CEO John Marotta told investors: "We are entering the year well positioned for continued success... I am confident in the path we are taking." On the same call, management reaffirmed full-year 2026 guidance of 3%-5% organic revenue growth and adjusted EBITDA margin expansion of approximately 300 basis points. CFO Laurence Flynn stated: "We remain confident that the strategic priorities outlined at Investor Day provide a clear roadmap to drive sustainable, profitable growth."
Three months later, on May 5, 2026, Azenta reported a $149 million goodwill impairment tied to its Multiomics segment, a $160.8 million net loss for the quarter, and reduced its FY 2026 revenue and margin guidance. The February 4 reaffirmation of full-year targets did not reference the goodwill impairment risk that was later reported in May.
If you purchased Azenta shares and suffered a loss, click here to discuss your legal rights with Levi & Korsinsky. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.
WHY LEVI & KORSINSKY -- Ranked in ISS Securities Class Action Services' Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights litigation. With a team of over 70 professionals, the firm has recovered hundreds of millions of dollars for investors.
Frequently Asked Questions About the AZTA Investigation
Q: Who is conducting the AZTA investigation? A: Levi & Korsinsky, LLP is investigating potential securities law violations on behalf of investors who purchased AZTA securities. The firm is nationally recognized, ranked in the ISS Top 50 for seven consecutive years, and has recovered hundreds of millions of dollars for aggrieved investors.
Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether Azenta made materially false or misleading statements regarding its full-year 2026 guidance, including the reaffirmation of 3%-5% organic revenue growth and approximately 300 basis points of margin expansion, while a $149 million goodwill impairment was pending. When the impairment and guidance reduction were disclosed, the stock declined significantly.
Q: Who is eligible to participate in the AZTA investigation? A: Investors who purchased AZTA stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.
Q: What do AZTA investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500. No immediate action is required to remain eligible to participate in the investigation.
Q: What if I already sold my AZTA shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought AZTA and sold at a loss may still participate in the investigation.
Q: What does it cost me to participate? A: Nothing. Securities investigations and any resulting actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.
Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either.
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Azenta and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On May 5, 2026, Azenta reported its second quarter fiscal 2026 financial results and updated its full-year outlook. Among other items, the Company disclosed that its second quarter results "fell short" of expectations, reflecting "both execution gaps and a more cautious demand environment." Azenta further disclosed that results were impacted by "costs related to Automated Stores rework" and that the Company recorded a $149 million non-cash goodwill impairment charge during the quarter. In addition, Azenta reduced its fiscal 2026 outlook, stating that organic revenue was now expected to range from down approximately 2% to up 1%, compared to prior guidance of 3% to 5% growth. The Company also reduced its adjusted EBITDA margin outlook and announced that it was extending the timeline for its long-range plan targets from 2028 to 2029.
On this news, Azenta's stock price fell $6.23 per share, or 25.31%, to close at $18.38 per share on May 6, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
, /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, demonstrating continued progress against its key ESG priorities. The report includes ESG data for the Company's fiscal year ended September 30, 2025.
The report offers a comprehensive overview of the Company's ESG approach, highlighting achievements across three core pillars:
Environmental Protection: We understand the broad scope of our operations and are committed to reducing our environmental impact while continuing to expand our business. Social Impact: We are committed to making a positive impact on society, particularly in the regions where we operate and serve our customers. Responsible Operations: Our products and services help enable our customers to have a significant positive impact on the world, and we are committed to ensuring the safety, quality, and reliability of our products and services. In 2025, we achieved key milestones in our ESG journey, including:
Disclosing our Scope 3 GHG emissions for the first time, establishing a value chain emissions baseline that sets the foundation for targeted reduction efforts and long-term climate action. Submitting near-term GHG reduction targets to the Science Based Targets initiative (SBTi) for validation, including a 45% absolute reduction in Scope 1 and 2 emissions and a 25% absolute reduction in Scope 3 emissions across key value chain categories by FY2033, from a FY2025 base year. Reducing our Scope 1 and 2 carbon footprint by approximately 40% compared to a FY2022 base year (market-based), while sourcing 72% of our electricity from renewable sources. Advancing sustainable innovation with products like the BioArc™ Ultra, providing our customers with cutting-edge solutions for large-scale, eco-friendly sample storage. Completing our second annual Global Well-being Week, offering employees programming across physical, financial, and mental well-being. Refreshing our Enterprise Risk Management (ERM) framework, with Board approval of updated risk assessment processes and clearer accountability across business units, strengthening our approach to enterprise and operational risk management. Expanding the Azenta Business System (ABS) across global operations, equipping teams with tools and capabilities to improve quality, reduce waste, and deliver better outcomes for customers. To learn more about Azenta's commitment to ESG efforts, view the report in full at https://investors.azenta.com/esg.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling life science organizations around the world to bring impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.
"Safe Harbor Statement" under Section 21E of the Securities Exchange Act of 1934
This press release contains forward‑looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Forward‑looking statements are based on current assumptions, expectations, and beliefs and include, without limitation, statements regarding the Company's ESG strategy and priorities; anticipated reductions in greenhouse gas emissions, including Scope 1, 2, and 3 reduction targets; the Company's ability to source renewable energy; expectations regarding sustainable product innovation, including the BioArc™ Ultra platform; plans to expand the Azenta Business System (ABS) across global operations; and other statements that are not historical facts.
Forward‑looking statements are not guarantees of future performance, and actual results may differ materially due to a variety of risks and uncertainties. These risks include, but are not limited to: the Company's ability to achieve its greenhouse gas emission reduction targets on the anticipated timeline or at all; changes in the cost, availability, or reliability of renewable energy sources; evolving ESG‑related laws, regulations, and reporting standards, including potential changes to SEC climate disclosure rules; the availability and accuracy of data used to measure and report ESG metrics, including Scope 3 emissions; the ability to successfully implement operational improvement initiatives; changes in customer expectations regarding sustainability; general market, industry, regulatory, or economic conditions; and other factors described in the Company's filings with the Securities and Exchange Commission, including the "Risk Factors" section of the Company's most recent Annual Report on Form 10‑K and subsequent Quarterly Reports on Form 10‑Q.
Forward‑looking statements speak only as of the date of this release. Azenta undertakes no obligation to publicly update or revise any forward‑looking statements, whether as a result of new information, future developments, or otherwise, except as required by law.
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA) investors concerning the Company's possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON AZENTA, INC. (AZTA), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.What Happened?On May 5, 2026, Azenta released its second quar.
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON AZENTA, INC. (AZTA), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.
What Happened?
On May 5, 2026, Azenta released its second quarter 2026 financial results, missing consensus estimates in EPS and revenue due to “execution-related shortfalls within [the Company’s] control” as well as “a more cautious prolonged demand environment.” The Company also reported a $149 million goodwill impairment.
Additionally, Azenta reduced its 2026 outlook, stating that organic revenue was now expected to range from down approximately 2% to up 1%, compared to prior guidance of 3% to 5% growth. The Company also reduced its adjusted EBITDA margin outlook and announced that it was extending the timeline for its long-range plan targets from 2028 to 2029.
On this news, Azenta’s stock price fell $6.23, or 25.3%, to close at $18.38 per share on May 6, 2026, thereby injuring investors.
Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
Charles Linehan, Esq.
Glancy Prongay Wolke & Rotter LLP
1925 Century Park East, Suite 2100
Los Angeles, California 90067
Email: [email protected]
Telephone: 310-201-9150 (Toll-Free: 888-773-9224)
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.
Whistleblower Notice
Persons with non-public information regarding Azenta should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Charles H. Linehan at 310-201-9150 or 888-773-9224 or email [email protected].
About Glancy Prongay Wolke & Rotter LLP
GPWR is a premier law firm with decades of experience representing investors and consumers in securities litigation and other complex class action litigation. Recognizing the firm’s recent successes, GPWR was named one of Law360’s Securities Groups of the Year and ranked second-highest in total investor recoveries by Institutional Shareholder Services Securities Class Action Services in 2025. GPWR’s lawyers have handled cases covering a wide spectrum of corporate misconduct and relating to nearly all industries and sectors. GPWR’s past successes have been widely covered by leading news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron’s, Investor’s Business Daily, Forbes, and Money. Prior results do not guarantee a similar outcome.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260522237239/en/
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA) on behalf of investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON AZENTA, INC. (AZTA), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.What Is The Investigation About?On May 5, 2026, Azenta released its second quarter 2026 financial results, missing.
The Law Offices of Frank R. Cruz continues its investigation of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON AZENTA, INC. (AZTA), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.
What Is The Investigation About?
On May 5, 2026, Azenta released its second quarter 2026 financial results, missing consensus estimates in EPS and revenue due to “execution-related shortfalls within [the Company’s] control” as well as “a more cautious prolonged demand environment.” The Company also reported a $149 million goodwill impairment.
Additionally, Azenta reduced its 2026 outlook, stating that organic revenue was now expected to range from down approximately 2% to up 1%, compared to prior guidance of 3% to 5% growth. The Company also reduced its adjusted EBITDA margin outlook and announced that it was extending the timeline for its long-range plan targets from 2028 to 2029.
On this news, Azenta’s stock price fell $6.23, or 25.3%, to close at $18.38 per share on May 6, 2026, thereby injuring investors.
Contact Us To Participate or Learn More:
If you purchased Azenta securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
The Law Offices of Frank R. Cruz,
2121 Avenue of the Stars, Suite 800,
Century City, California 90067
Call us at: 310-914-5007
Visit our website at: www.frankcruzlaw.com.
Email us at: [email protected]
Follow us for updates on Twitter at twitter.com/FRC_LAW.
If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260522116288/en/
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA) investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN AZENTA, INC. (AZTA), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmi.
New York, New York--(Newsfile Corp. - May 25, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Azenta, Inc. (NASDAQ: AZTA) ("Azenta, Inc.") concerning potential violations of the federal securities laws.
On February 4, 2026, CEO John Marotta told investors Azenta was "entering the year well positioned for continued success" and reaffirmed FY 2026 guidance of 3%-5% organic revenue growth with approximately 300 basis points of adjusted EBITDA margin expansion. On May 5, 2026, the Company reported Q2 FY 2026 results that included a $149 million goodwill impairment charge in its Multiomics segment. The resulting net loss of $160.8 million stood in stark contrast to the growth trajectory management had presented ninety days prior.
Alongside the impairment, Azenta reduced its full-year FY 2026 guidance -- trimming the revenue growth and margin expansion targets it had publicly reaffirmed in February. The gap between the Company's stated outlook and its reported results is now the subject of an investigation into potential securities law violations.
If you suffered a loss on your Azenta, Inc. securities and would like to explore a potential recovery under the federal securities laws, Learn More About the Investigation or contact Joseph E. Levi, Esq. via email at [email protected] or call (212)363-7500 to speak to our team of experienced shareholder advocates.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004 [email protected]
Tel: (212)363-7500
Fax: (212)363-7171
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/298723
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Azenta and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On May 5, 2026, Azenta reported its second quarter fiscal 2026 financial results and updated its full-year outlook. Among other items, the Company disclosed that its second quarter results “fell short” of expectations, reflecting “both execution gaps and a more cautious demand environment.” Azenta further disclosed that results were impacted by “costs related to Automated Stores rework” and that the Company recorded a $149 million non-cash goodwill impairment charge during the quarter. In addition, Azenta reduced its fiscal 2026 outlook, stating that organic revenue was now expected to range from down approximately 2% to up 1%, compared to prior guidance of 3% to 5% growth. The Company also reduced its adjusted EBITDA margin outlook and announced that it was extending the timeline for its long-range plan targets from 2028 to 2029.
On this news, Azenta’s stock price fell $6.23 per share, or 25.31%, to close at $18.38 per share on May 6, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
Azenta, Inc. reaffirmed 3%-5% organic revenue growth and 300 basis points of margin expansion in February 2026 -- then cut both targets three months later after recording a $149 million goodwill impairment.
, /PRNewswire/ -- Shareholders who purchased Azenta, Inc. (NASDAQ: AZTA) stock lost significant value after the Company slashed its FY 2026 guidance on May 5, 2026 -- reversing projections it had publicly reaffirmed just three months earlier. Those who suffered losses are encouraged to submit their information to Levi & Korsinsky. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.
On February 4, 2026, during the Q1 FY 2026 earnings call, CEO John Marotta told investors: "We are reaffirming our guidance for fiscal 2026 with organic revenue growth expected in the range of 3% to 5%…we are also reaffirming our target of approximately 300 basis points of year-over-year adjusted EBITDA margin expansion." CFO Laurence Flynn added that the Company's strategic priorities provided "a clear road map to drive sustainable, profitable growth." Neither executive disclosed any risk of the goodwill impairment that followed.
On May 5, 2026, Azenta reported Q2 FY 2026 results that included a $149 million goodwill impairment and a $160.8 million net loss. The Company simultaneously reduced its full-year revenue and margin guidance. The gap between the February reaffirmation and the May revision raises the question of what conditions had changed -- and when management became aware of them.
If you lost money on your Azenta investment, click here to discuss your legal rights with Levi & Korsinsky. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.
Levi & Korsinsky, LLP | Top 50 Securities Firm | (212) 363-7500 | www.zlk.com
Frequently Asked Questions About the AZTA Investigation
Q: Which statements are being investigated as potentially misleading?A: The investigation concerns whether Azenta made materially false or misleading statements regarding its FY 2026 revenue and margin guidance, including the February 2026 reaffirmation of 3%-5% organic growth and 300 basis points of margin expansion. When the Company disclosed a $149 million goodwill impairment and cut guidance on May 5, 2026, the stock declined sharply.
Q: Who is eligible to participate in the AZTA investigation?A: Investors who purchased AZTA stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.
Q: What do AZTA investors need to do right now?A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500. No immediate action is required to remain eligible to participate in the investigation.
Q: What happens after I contact Levi & Korsinsky?A: An attorney will review your trading history at no cost and provide an initial assessment of your potential recovery.
Q: What if I already sold my AZTA shares -- can I still recover losses?A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought AZTA and sold at a loss may still participate in the investigation.
Q: What does it cost me to participate?A: Nothing. Securities investigations and any resulting actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.
Q: What if I live outside the United States?A: U.S. securities fraud investigations generally cover purchases on U.S. exchanges regardless of the investor's country of residence.
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Azenta and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices
[Click here for information about joining the class action]
On May 5, 2026, Azenta reported its second quarter fiscal 2026 financial results and updated its full-year outlook. Among other items, the Company disclosed that its second quarter results "fell short" of expectations, reflecting "both execution gaps and a more cautious demand environment." Azenta further disclosed that results were impacted by "costs related to Automated Stores rework" and that the Company recorded a $149 million non-cash goodwill impairment charge during the quarter. In addition, Azenta reduced its fiscal 2026 outlook, stating that organic revenue was now expected to range from down approximately 2% to up 1%, compared to prior guidance of 3% to 5% growth. The Company also reduced its adjusted EBITDA margin outlook and announced that it was extending the timeline for its long-range plan targets from 2028 to 2029.
On this news, Azenta's stock price fell $6.23 per share, or 25.31%, to close at $18.38 per share on May 6, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
On May 28, 2026, Azenta Inc AZTA shares rose 5.4%, bringing the current price to $22.49. The stock has experienced considerable volatility, with a 52-week range between $15.93 and $41.73.
GF Value™ verdict: Currently priced at $22.49, AZTA is estimated to be 64.5% undervalued relative to its GF Value™ of $63.31.GF Score™: AZTA has a score of 72/100, indicating it is ranked as Above Average in terms of potential performance.Most notable signal: Insiders have shown confidence by purchasing $0.2 million worth of stock in the last 3 months with no selling activity reported. Is AZTA Overvalued or Undervalued? The current price of Azenta Inc AZTA at $22.49 stands in stark contrast to its GF Value™ of $63.31, suggesting a potential upside of 64.5%. This significant margin of safety presents a compelling opportunity for value-oriented investors. However, it is important to note that GF Valuation has labeled AZTA as a Possible Value Trap, indicating caution should be exercised due to potential risks associated with this valuation. GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates.
While the substantial undervaluation may attract interest, investors should consider the underlying financial metrics and overall market conditions that could impact the stock's future performance. The recent declines in the stock price over various timeframes, including a year-to-date decrease of 32.4% and a 1-year decline of 17.0%, suggest that there may be underlying issues or market sentiment affecting the stock's trajectory.
How Does AZTA's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 59.3x 2.6x Azenta Inc's current P/E ratio of 59.3x is significantly above its 5-year median P/E of 2.6x. This analysis suggests that the stock is trading at a historically high valuation level, which may contradict the GF Value™ verdict indicating that the stock is undervalued. The elevated P/E ratio raises concerns regarding whether the current price reflects an accurate valuation considering historical performance ratios.
What Does AZTA's GF Score™ Tell Us? Metric Rating GF Score™ 72/100 Financial Strength 7/10 Profitability 5/10 Growth 8/10 Valuation 2/10 Momentum 5/10 The GF Score™ of 72/100 indicates that Azenta Inc has a solid potential for long-term returns, particularly driven by its Growth Rank of 8/10 and Financial Strength of 7/10. However, the Valuation Rank of 2/10 highlights that the stock may currently be overvalued in relation to its intrinsic value, suggesting that while the company has strong growth potential, its current market price does not reflect this strength adequately.
What Are Insiders Doing with AZTA Stock? Insider activity at Azenta Inc has shown a bullish sentiment, with insiders purchasing $0.2 million worth of shares in the last three months and no selling activity reported. This trend suggests that those closest to the company have confidence in its future performance and intrinsic value, which can be a positive signal for potential investors. However, it is essential to consider the broader market context and financial health of the company before drawing conclusions solely based on insider transactions.
What This Means for Investors Based on the analysis, Azenta Inc AZTA is currently undervalued according to GF Value™, with a significant margin of safety relative to its intrinsic value. However, the high P/E ratio and the possible value trap status warrant caution. Investors should weigh the potential upside against the risks associated with the current valuation and market conditions.
For the complete analysis, visit the Azenta Inc AZTA stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions What is AZTA's GF Score™?
AZTA has a GF Score™ of 72/100, indicating it is ranked as Above Average in potential performance relative to other stocks.
Is AZTA overvalued or undervalued?
According to GF Value™, AZTA is currently undervalued, with a significant margin of safety of 64.5% compared to its estimated fair value.
What is AZTA's P/E ratio?
AZTA's current P/E ratio is 59.3x, which is substantially higher than its 5-year median P/E of 2.6x, indicating the stock is trading at a much higher valuation compared to its historical performance.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Azenta and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On May 5, 2026, Azenta reported its second quarter fiscal 2026 financial results and updated its full-year outlook. Among other items, the Company disclosed that its second quarter results “fell short” of expectations, reflecting “both execution gaps and a more cautious demand environment.” Azenta further disclosed that results were impacted by “costs related to Automated Stores rework” and that the Company recorded a $149 million non-cash goodwill impairment charge during the quarter. In addition, Azenta reduced its fiscal 2026 outlook, stating that organic revenue was now expected to range from down approximately 2% to up 1%, compared to prior guidance of 3% to 5% growth. The Company also reduced its adjusted EBITDA margin outlook and announced that it was extending the timeline for its long-range plan targets from 2028 to 2029.
On this news, Azenta’s stock price fell $6.23 per share, or 25.31%, to close at $18.38 per share on May 6, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Azenta and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On May 5, 2026, Azenta reported its second quarter fiscal 2026 financial results and updated its full-year outlook. Among other items, the Company disclosed that its second quarter results "fell short" of expectations, reflecting "both execution gaps and a more cautious demand environment." Azenta further disclosed that results were impacted by "costs related to Automated Stores rework" and that the Company recorded a $149 million non-cash goodwill impairment charge during the quarter. In addition, Azenta reduced its fiscal 2026 outlook, stating that organic revenue was now expected to range from down approximately 2% to up 1%, compared to prior guidance of 3% to 5% growth. The Company also reduced its adjusted EBITDA margin outlook and announced that it was extending the timeline for its long-range plan targets from 2028 to 2029.
On this news, Azenta's stock price fell $6.23 per share, or 25.31%, to close at $18.38 per share on May 6, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
